Skip to content

Discontinued — last reported Q1 '23

Gross margin at other companies

Abbott logo
AbbottABT
56.3%+0.4pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
67.8%-0.5pp
Boston Scientific logo
Boston ScientificBSX
69.2%+0.5pp
Medtronic logo
MedtronicMDT
65%-0.3pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
48.7%+0.9pp
ITG
Integer HoldingsITGR
26.4%-0.6pp

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
Enterprise value$1.73B+48.1%
P/S2,391.5×

Profitability

See full
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 11, 2023, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s gross margin?
Pulse Biosciences, Inc. (PLSE) reported gross margin of -4,067.5% in Q1 2023.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.